Chronic diffuse musculoskeletal pain, fibromyalgia and co-morbid unexplained clinical conditions

被引:106
|
作者
Aaron, LA
Buchwald, D
机构
[1] Univ Washington, Dept Oral Med, Seattle, WA 98195 USA
[2] Univ Washington, Dept Med, Seattle, WA 98104 USA
来源
关键词
fibromyalgia; chronic musculoskeletal pain; chronic fatigue syndrome; screening; treatment;
D O I
10.1016/S1521-6942(03)00033-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This chapter reviews our current knowledge on the presence of overlapping syndromes in one form of chronic diffuse pain, fibromyalgia. Patients with fibromyalgia often present with signs and symptoms of other unexplained clinical conditions, including chronic fatigue syndrome, irritable bowel syndrome, temporomandibular disorders, and multiple chemical sensitivities. The high prevalence, impact on function and opportunities for treatment underscore the need for clinicians and researchers to screen routinely for co-morbid unexplained clinical conditions among persons with fibromyalgia. We, therefore, describe a simple approach to screening for such conditions in accordance with published criteria. Interventions should directly address both fibromyalgia symptoms and co-morbid unexplained clinical conditions, as well as the multiple factors that propagate pain, fatigue and limitations in function.
引用
收藏
页码:563 / 574
页数:12
相关论文
共 50 条
  • [21] Duloxetine treatment of pediatric chronic pain and co-morbid major depressive disorder
    Meighen, Karen G.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2007, 17 (01) : 121 - 127
  • [22] An open-label clinical trial of milnacipran in fibromyalgia syndrome with co-morbid depressive symptoms
    Nagaoka, S
    Ohno, M
    Sekiguchi, A
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2004, 8 (01) : 47 - 51
  • [23] A Study of Co-Morbid Conditions Associated with Psoriasis
    Ahmed, N. Ashwak
    JOURNAL OF RESEARCH IN MEDICAL AND DENTAL SCIENCE, 2021, 9 (07): : 465 - 465
  • [24] Medication burden attributable to chronic co-morbid conditions in the very old and vulnerable
    Moore, Kelly L.
    Patel, Kanan
    Boscardin, W. John
    Steinman, Michael A.
    Ritchie, Christine
    Schwartz, Janice B.
    PLOS ONE, 2018, 13 (04):
  • [25] Effect of Chemotherapy on Chronic Co-morbid Conditions in Elderly Breast Cancer Patients
    Demissie, Kitaw
    Swerdel, Joel
    Gerhard, Tobias
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 225 - 225
  • [26] Musculoskeletal pain and co-morbid insomnia in adults; a population study of the prevalence and impact on restricted social participation
    Baker, Shula
    McBeth, John
    Chew-Graham, Carolyn A.
    Wilkie, Ross
    BMC FAMILY PRACTICE, 2017, 18 : 1 - 9
  • [27] Musculoskeletal pain and co-morbid insomnia in adults; a population study of the prevalence and impact on restricted social participation
    Shula Baker
    John McBeth
    Carolyn A. Chew-Graham
    Ross Wilkie
    BMC Family Practice, 18
  • [28] INFLAMMATORY BIOMARKERS ARE ASSOCIATED WITH CO-MORBID PAIN CONDITIONS IN UCPPS PATIENTS: A MAPP STUDY
    Bradley, Catherine
    Schrepf, Andrew
    Lutgendorf, Susan
    O'Donnell, Michael
    Luo, Yi
    Kreder, Karl
    JOURNAL OF UROLOGY, 2014, 191 (04): : E212 - E212
  • [29] Abdominal Pain and Co-Morbid Complaints in Dutch Schoolchildren
    van der Veek, Shelley
    Derkx, Bert
    de Haan, Else
    Benninga, Marc A.
    Boer, Frits
    GASTROENTEROLOGY, 2010, 138 (05) : S356 - S356
  • [30] Co-morbid pain and obesity: Obstacles for treatment outcome
    Sellinger, John J.
    Shulman, Marc
    Heapy, Alicia A.
    Rosenberger, Patricia H.
    Kerns, Robert D.
    ANNALS OF BEHAVIORAL MEDICINE, 2008, 35 : S223 - S223